Fluzone

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

Systems Investigation of Vaccine Responses in Aging and Frailty

Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

Comparison of Three Licensed Influenza Vaccines

The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection

Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)

Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age

Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children

Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children

B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)

B-cell Immunity to Influenza (SLVP017)- Year 5, 2013

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4

Immune Responses Induced by Different Licensed Influenza Vaccines

Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)

Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults

Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)